Predictive model for HBsAg clearance rate in chronic hepatitis B patients treated with pegylated interferon α-2b for 48 weeks.

Hepatol Int · 2025 · PMC12003487 · PMID 39702655

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Conclusion In this analysis, three validated predictors, including gender, baseline HBsAg levels, and cirrhosis, are highly significant in predicting the probability of HBsAg clearance in CHB patients after 48 weeks of Peg-IFN-2b therapy.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.